Ashok Leyland skids 2% on profit-booking, subsidiary secures $50-mn funding

The capital infusion will empower the company to bolster its research and development capabilities, leveraging organic growth and strategic acquisitions.

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *